Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Nanomedicine 2010: Visions for the Future, 24-25 February, Amsterdam

Professor Vladimir Torchilin
Professor Vladimir Torchilin

Abstract:
In a fascinating keynote presentation at Nanomedicine 2010: Visions for the Future, Professor Vladimir Torchilin shows how nanotechnology is being applied to make novel multifunctional pharmaceutical nanocarriers to meet some of these major challenges to delivering modern advanced pharmaceuticals safely and efficiently.

Nanomedicine 2010: Visions for the Future, 24-25 February, Amsterdam

Scotland | Posted on January 21st, 2010

Multifunctional pharmaceutical nanocarriers

Carriers are needed for a number of reasons in drug delivery, e.g. to protect the drug from the body, to protect the body from the drug and to adjust the pharmacokinetics, i.e. distribution and clearance, of the drug. In addition it is also necessary to use approved components, to make the preparation process simple and scalable, to make a reproducible product with easy to control properties and to make the product economically.

Vladimir P. Torchilin, PhD, DSc is Distinguished Professor of Pharmaceutical Sciences and Director, Center for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University, Boston, Massachusetts. He graduated from Moscow University and also obtained his PhD and DSc there in polymer chemistry, chemical kinetics and catalysis, and chemistry of physiologically active compounds. In 1991 he joined Massachusetts General Hospital and Harvard Medical School as the Head of the Chemistry Program and Associate Professor of Radiology. Since 1998 Dr. Torchilin has been with Northeastern University where he was Chair of the Department of Pharmaceutical Sciences from1998-2008. His research interests have focused on biomedical polymers, polymeric drugs, immobilized medicinal enzymes, drug delivery and targeting, pharmaceutical nanocarriers for diagnostic and therapeutic agents, and experimental cancer immunology. He has published more than 300 original papers, more than 100 reviews and book chapters, has written and edited10 books, and holds more that 40 patents.

To register for Nanomedicine 2010: Visions for the Future, visit:

www.nano.org.uk/payments/buildOrder_courses.php


####

About The Institute of Nanotechnology
The Institute of Nanotechnology (IoN) was founded by Ottilia Saxl in January 1997. It is a registered Charity, whose core activities are focused on education and training in nanotechnology, in the widest sense. It grew out of the Centre for Nanotechnology, part funded by the DTI through the UK 's National Initiative on Nanotechnology (NION). The Institute was one of the world's first nanotechnology information providers and is now a global leader.

IoN works closely with governments, universities, researchers, companies and the general public to educate and inform on all aspects of nanotechnology. It is also an organizer of international scientific events, conferences and educational courses that examine the implications of nanotechnology for industry, society, health, energy and the environment, and the disadvantaged communities across the globe.

For more information, please click here

Contacts:
Carrie Smith
Manager, Conferences and Events
Institute of Nanotechnology
t: +44 (0)141 303 8444 ext.110
f: +44 (0)141 552 7499

Copyright © The Institute of Nanotechnology

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024

Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Nanomedicine

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery: NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery September 13th, 2024

Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024

Nanobody inhibits metastasis of breast tumor cells to lung in mice: “In the present study we describe the development of an inhibitory nanobody directed against an extracellular epitope present in the native V-ATPase c subunit.” August 16th, 2024

Announcements

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Turning up the signal November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024

Events/Classes

A New Blue: Mysterious origin of the ribbontail ray’s electric blue spots revealed July 5th, 2024

Researchers demonstrate co-propagation of quantum and classical signals: Study shows that quantum encryption can be implemented in existing fiber networks January 20th, 2023

CEA & Partners Present ‘Powerful Step Towards Industrialization’ Of Linear Si Quantum Dot Arrays Using FDSOI Material at VLSI Symposium: Invited paper reports 3-step characterization chain and resulting methodologies and metrics that accelerate learning, provide data on device pe June 17th, 2022

June Conference in Grenoble, France, to Explore Pathways to 6G Applications, Including ‘Internet of Senses’, Sustainability, Extended Reality & Digital Twin of Physical World: Organized by CEA-Leti, the Joint EuCNC and 6G Summit Sees Telecom Sector as an ‘Enabler for a Sustainabl June 1st, 2022

Nanobiotechnology

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery: NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery September 13th, 2024

Nanobody inhibits metastasis of breast tumor cells to lung in mice: “In the present study we describe the development of an inhibitory nanobody directed against an extracellular epitope present in the native V-ATPase c subunit.” August 16th, 2024

The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project